Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of Director and Officer
On December 9, 2022, Mr. Daniel Johnson tendered his resignation as the Chief
Financial Officer and as a director of ABG Acquisition Corp. I (the "Company"),
effective December 9, 2022. The resignation of Mr. Johnson was not a result of
any disagreement with the Company's operations, policies or procedures.
Appointment of Director and Officer
Effective December 14, 2022, the board of directors of the Company has appointed
Kevin C. Reilly as a director of the Company and as Chief Financial Officer,
filling the vacancy left by Mr. Johnson.
Mr. Reilly, age 32, joined Ally Bridge Group in 2021 and is currently a managing
director focused on private equity strategies in healthcare market sectors.
Before joining Ally Bridge Group, Mr. Reilly was a principal focused on medical
technology investments at CRG, L.P., a healthcare investment management firm
providing growth capital to companies through the form of long-term debt and
equity, beginning in 2014. Mr. Reilly began his career in 2012 in the Healthcare
Investment Banking Group at Stifel, Nicolaus & Company, Inc. Mr. Reilly holds a
Bachelor of Science degree in Finance and Information Systems from the
University of Maryland.
In connection with Mr. Reilly's appointment as Chief Financial Officer and a
director of the Company, the Company entered into the following agreements:
• A Letter Agreement, as of December 14, 2022 (the "Letter Agreement"),
between the Company and Mr. Reilly, pursuant to which Mr. Reilly agreed
to: vote any ordinary shares of the Company held by him in favor of the
Company's initial business combination; facilitate the liquidation and
winding up of the Company if an initial business combination is not
consummated within the time period required by its amended and restated
memorandum and articles of association; and certain transfer restrictions
with respect to the Company's securities.
• An Indemnity Agreement, as of December 14, 2022 (the "Indemnity
Agreement"), between the Company and Mr. Reilly, providing Mr. Reilly
certain contractual indemnification in addition to the indemnification
provided for in the Company's amended and restated memorandum and
articles of association.
Mr. Reilly is not expected to enter into an employment agreement or receive any
compensation from the Company for serving as the Company's Chief Financial
Officer and as a director. Mr. Reilly is not expected to be appointed to any
committees of the Company's board of directors.
--------------------------------------------------------------------------------
Other than as disclosed above, there are no arrangements or understandings
between Mr. Reilly and any other persons pursuant to which Mr. Reilly was
selected as a director and an executive officer of the Company. There are no
family relationships between Mr. Reilly and any of the Company's other directors
or executive officers and Mr. Reilly does not have any direct or indirect
material interest in any transaction required to be disclosed pursuant to Item
404(a) of Regulation S-K.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses